AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

BriaCell Therapeutics Corp. Warrant

$0.13 -$0.11 (-46.94%)
NASDAQ · 14 Sep 2026 20:00 UTC
Previous Close
$0.14
Day Range
$0.12$0.13
Year Range
$0.13$0.13
Market Cap
244.89K
AVG Volume
131.84K
Trailing/Forward PE
-0.29/-
PEG ratio
0.01
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
NASDAQUS
Net Income (USD) · TTM
-40M-30M-20M-10M024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
BCTXZ Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q3-30.65M
26 Q2-29.62M
26 Q1-28.69M
25 Q4-26.29M
25 Q3-19.42M
25 Q2-11.59M
25 Q1-16.66M
24 Q4-4.95M
24 Q3-6.19M
24 Q2-12.77M
Operating Income (USD) · TTM
-40M-30M-20M-10M024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
BCTXZ Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q3-32.01M
26 Q2-30.71M
26 Q1-30.35M
25 Q4-27.18M
25 Q3-24.34M
25 Q2-27.17M
25 Q1-29.9M
24 Q4-33.13M
24 Q3-35.22M
24 Q2-31.71M
EBITDA (USD) · TTM
-40M-30M-20M-10M024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
BCTXZ EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q3-31.48M
26 Q2-30.47M
26 Q1-30.11M
25 Q4-26.94M
25 Q3-24.05M
25 Q2-27.05M
25 Q1-29.79M
24 Q4-33.04M
24 Q3-35.2M
24 Q2-31.69M
Cash Flows (USD) · TTM
-40M-30M-20M-10M021 Q221 Q323 Q424 Q125 Q225 Q325 Q426 Q126 Q226 Q3
BCTXZ Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q3-30.95M
26 Q2-30.97M
26 Q1-28.92M
25 Q4-28.17M
25 Q3-24.55M
25 Q2-22.37M
24 Q1-27.85M
23 Q4-23.82M
21 Q3-7.87M
21 Q2-593.88K
EPS (USD) · TTM
-300-200-100024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
BCTXZ EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q3-12.2
26 Q2-27.61
26 Q1-48.34
25 Q4-76.66
25 Q3-82.35
25 Q2-49.97
25 Q1-133.35
24 Q4-174.11
24 Q3-187.06
24 Q2-250.17
Expenses (USD) · TTM
010M20M30M40MR&DSG&ACapex24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
BCTXZ Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
24 Q10
23 Q40
21 Q30
21 Q20
26 Q332.11M
26 Q230.69M
26 Q130.33M
25 Q427.16M
25 Q324.72M
25 Q227.55M
25 Q129.82M
24 Q433.04M
24 Q335.2M
24 Q231.69M
Shares Outstanding (USD) · TTM
-1.5M-1M-500K0500KBuybacks (Repurchases)Stock-Based Compensation21 Q221 Q323 Q424 Q125 Q225 Q325 Q426 Q126 Q226 Q3
BCTXZ Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
26 Q3-1.01M
26 Q2-805.36K
26 Q1-804.59K
25 Q4-776.88K
25 Q3-776.88K
25 Q2-552.06K
24 Q1398
23 Q446.69K
21 Q30
21 Q20
Employee Count
010203020212022202320242025
BCTXZ Employee Count by quarter
PeriodEmployee Count
202522
202417
202311
202211
20212
Free Cash Flow Yield
-50000%-40000%-30000%-20000%-10000%0%med -8068.57%Jun 25Aug 25Nov 25Jan 26Apr 26Jun 26Sep 26
BCTXZ Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-2962.09%
Sep 26-2307.23%
Aug 26-3161.75%
Aug 26-4065.11%
Aug 26-3880.33%
Aug 26-4785.17%
Jul 26-4747.91%
Jul 26-4281.21%
Jul 26-4272.64%
Jul 26-4272.64%
Jul 26-4742.63%
Jun 26-13829.82%
Jun 26-13864.53%
Jun 26-13829.82%
Jun 26-13899.41%
May 26-13812.53%
May 26-13812.53%
May 26-13829.82%
May 26-12291.47%
May 26-11755.35%
Apr 26-10523.84%
Apr 26-7748.97%
Apr 26-7366.68%
Apr 26-10045.48%
Mar 26-11808.05%
Mar 26-13371.48%
Mar 26-9314.6%
Mar 26-10586.52%
Feb 26-9158.99%
Feb 26-9164.45%
Feb 26-10233.64%
Feb 26-8771.69%
Jan 26-8068.57%
Jan 26-9303.31%
Jan 26-7675.23%
Jan 26-5685.36%
Jan 26-6265.49%
Dec 25-4984.17%
Dec 25-3833.97%
Dec 25-4146.56%
Dec 25-3867.69%
Nov 25-3996.93%
Nov 25-5191.84%
Nov 25-3924.54%
Nov 25-4984.17%
Oct 25-3733.46%
Oct 25-3251.25%
Oct 25-3603.88%
Oct 25-3338.36%
Oct 25-3324.26%
Sep 25-23468.41%
Sep 25-30923.09%
Sep 25-31668.22%
Sep 25-34585.03%
Aug 25-41044.07%
Aug 25-29868.89%
Aug 25-26295.14%
Aug 25-24446.26%
Aug 25-23476.8%
Jul 25-18801.59%
Jul 25-18780.1%
Jul 25-13139.68%
Jul 25-6199.2%
Jun 25-7744.36%
Jun 25-8123.99%
Jun 25-8382.02%
Jun 25-7891.88%
May 25-7533.15%
May 25-7744.36%
May 25-8204.43%
May 25-8815.39%
May 25-7022.43%
Apr 25-6325.55%
Price to Book
00.050.10.15med 0.03Jun 25Aug 25Nov 25Jan 26Apr 26Jun 26Sep 26
BCTXZ Price to Book by quarter
PeriodPrice to Book
Sep 260.04
Sep 260.06
Aug 260.04
Aug 260.03
Aug 260.03
Aug 260.03
Jul 260.03
Jul 260.03
Jul 260.03
Jul 260.03
Jul 260.03
Jun 260.01
Jun 260.01
Jun 260.01
Jun 260.01
May 260.01
May 260.01
May 260.01
May 260.01
May 260.01
Apr 260.01
Apr 260.01
Apr 260.01
Apr 260.01
Mar 260.03
Mar 260.02
Mar 260.03
Mar 260.03
Feb 260.03
Feb 260.03
Feb 260.03
Feb 260.04
Jan 260.04
Jan 260.03
Jan 260.04
Jan 260.05
Jan 260.05
Dec 250.03
Dec 250.04
Dec 250.04
Dec 250.04
Nov 250.04
Nov 250.03
Nov 250.04
Nov 250.03
Oct 250.04
Oct 250.05
Oct 250.04
Oct 250.05
Oct 250.05
Sep 250.01
Sep 250.01
Sep 250.01
Sep 250.01
Aug 250.01
Aug 250.01
Aug 250.01
Aug 250.01
Aug 250.01
Jul 250.01
Jul 250.01
Jul 250.02
Jul 250.03
Jun 250.09
Jun 250.09
Jun 250.08
Jun 250.09
May 250.09
May 250.09
May 250.08
May 250.08
May 250.1
Apr 250.11
BriaCell Therapeutics Corp. Warrant
BCTXZ
Stockpicker

Video analysis: BCTXZ

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.